(Q51406608)

4 April 2018

title

Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. (English)

1 reference

4 April 2018

author name string

King GR

1

1 reference

4 April 2018

Xiong Z

2

1 reference

4 April 2018

Douglass S

3

1 reference

4 April 2018

Ellinwood EH

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

4 April 2018

European Journal of Pharmacology

published in

1 reference

4 April 2018

volume

394

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

97-101

1 reference

4 April 2018

Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

The breadth of action of the 5-HT3 receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

The psychopharmacology of 5-HT3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Rating the behavioral effects of amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Cocaine behavioral sensitization and the excitatory amino acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

DNQX blockade of amphetamine behavioral sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Amphetamine behavioral sensitization and the excitatory amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Dopamine efflux during withdrawal from continuous or intermittent cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Extracellular cocaine and dopamine concentrations are linearly related in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900926-7

10.1016/S0014-2999(99)00926-7

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

10771040

1 reference

4 April 2018